Your browser doesn't support javascript.
loading
Group-randomized trial of tailored brief shared decision-making to improve asthma control in urban black adults.
George, Maureen; Bruzzese, Jean-Marie; Lynn S Sommers, Marilyn; Pantalon, Michael V; Jia, Haomiao; Rhodes, Joseph; Norful, Allison A; Chung, Annie; Chittams, Jesse; Coleman, Danielle; Glanz, Karen.
Afiliação
  • George M; Columbia University School of Nursing, New York, NY, USA.
  • Bruzzese JM; Columbia University School of Nursing, New York, NY, USA.
  • Lynn S Sommers M; University of Pennsylvania School of Nursing, Philadelphia, PA, USA.
  • Pantalon MV; Department of Emergency Medicine, Yale University School of Medicine, New Haven, CT, USA.
  • Jia H; Columbia University School of Nursing, Columbia University Mailman School of Public Health, New York, NY, USA.
  • Rhodes J; University of Pennsylvania School of Nursing, Philadelphia, PA, USA.
  • Norful AA; Columbia University School of Nursing, New York, NY, USA.
  • Chung A; Center for Health Behavior Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Chittams J; Biostatistics Analysis Core, University of Pennsylvania School of Nursing, Philadelphia, PA, USA.
  • Coleman D; Xxxx, Philadelphia, PA, USA.
  • Glanz K; Perelman School of Medicine and School of Nursing, University of Pennsylvania, Philadelphia, PA, USA.
J Adv Nurs ; 77(3): 1501-1517, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33249632
ABSTRACT

AIMS:

To assess the intervention effects of BREATHE (BRief intervention to Evaluate Asthma THErapy), a novel brief shared decision-making intervention and evaluate feasibility and acceptability of intervention procedures.

DESIGN:

Group-randomized longitudinal pilot study.

METHODS:

In total, 80 adults with uncontrolled persistent asthma participated in a trial comparing BREATHE (N = 40) to a dose-matched attention control intervention (N = 40). BREATHE is a one-time shared decision-making intervention delivered by clinicians during routine office visits. Ten clinicians were randomized and trained on BREATHE or the control condition. Participants were followed monthly for 3 months post-intervention. Data were collected from December 2017 - May 2019 and included surveys, lung function tests, and interviews.

RESULTS:

Participants were Black/multiracial (100%) mostly female (83%) adults (mean age 45). BREATHE clinicians delivered BREATHE to all 40 participants with fidelity based on expert review of audiorecordings. While the control group reported improvements in asthma control at 1-month and 3-month follow-up, only BREATHE participants had better asthma control at each timepoint (ß = 0.77; standard error (SE)[0.17]; p ≤ 0.0001; ß = 0.71; SE[0.16]; p ≤ 0.0001; ß = 0.54; SE[0.15]; p = .0004), exceeding the minimally important difference. BREATHE participants also perceived greater shared decision-making occurred during the intervention visit (ß = 7.39; SE[3.51]; p = .03) and fewer symptoms at follow-up (e.g., fewer nights woken, less shortness of breath and less severity of symptoms) than the controls. Both groups reported improved adherence and fewer erroneous medication beliefs.

CONCLUSION:

BREATHE is a promising brief tailored intervention that can be integrated into office visits using clinicians as interventionists. Thus, BREATHE offers a pragmatic approach to improving asthma outcomes and shared decision-making in a health disparity population. IMPACT The study addressed the important problem of uncontrolled asthma in a high-risk vulnerable population. Compared with the dose-matched attention control condition, participants receiving the novel brief tailored shared decision-making intervention had significant improvements in asthma outcomes and greater perceived engagement in shared decision-making. Brief interventions integrated into office visits and delivered by clinicians may offer a pragmatic approach to narrowing health disparity gaps. Future studies where other team members (e.g., office nurses, social workers) are trained in shared decision-making may address important implementation science challenges as it relates to adoption, maintenance, and dissemination. TRAIL REGISTRATION clinicaltrials.gov # NCT03300752.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Negro ou Afro-Americano Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Negro ou Afro-Americano Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article